London
26 °C
Manchester
Glasgow
19 °C
Dublin
Belfast
Washington
Denver
Atlanta
Dallas
31 °C
Houston Texas
New Orleans
31 °C
El Paso
Phoenix
Los Angeles
0 °C
9 °C
24 °C
23 °C
28 °C
Featured
Last news
Bangladesh measles deaths near 500 but vaccines offer hope
Bangladesh has rolled out a mass vaccination campaign to combat its deadliest measles outbreak in decades that has killed nearly 500 children in just two months, the United Nations children's agency said Wednesday.
Pressure mounts at United Nations for climate change 'lifeline'
The United Nations General Assembly on Wednesday considers a resolution reinforcing states' obligations to combat climate change, a long-awaited move toned down under pressure from major greenhouse gas emitters.
Acting US attorney general defends fund for prosecuted Trump allies
Acting US Attorney General Todd Blanche on Tuesday defended the creation of a nearly $1.8 billion fund to compensate political allies of President Donald Trump who believe they were unfairly prosecuted under the Biden administration.
Jaguar Health Reports First Quarter 2026 Financials
Net revenue increased 816% in Q1 2026 vs. Q1 2025, and increased 527% in Q1 2026 vs. Q4 2025, buoyed by license of U.S. commercial rights for Mytesi® and Canalevia®-CA1Company continues its focus on crofelemer development efforts for rare-disease intestinal failure indications; two crofelemer presentations in pediatric intestinal failure patients with microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) to be made at 58th Annual European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN) Meeting in June 2026REMINDERS: Jaguar to host investor webcast Tuesday, May 26 at 8:30 a.m. Eastern regarding Q1 2026 financials and company updates (click here to register); Jaguar CEO Lisa Conte to present virtually on Thursday, May 28 at 10 a.m. Eastern at Lytham Partners Spring 2026 Investor Conference (click here to register)
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
Company to advance additional preclinical studies and pursue government partnership opportunities for bucillamine as a potential franchise asset for infectious diseases, nerve-agent exposure, future pandemics and medical countermeasure stockpiling
Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association
Collaboration with USEA for Zomedica's PulseVet® shock wave system will increase brand awareness among Eventing enthusiasts.
Shock and bafflement at San Diego mosque where three were killed
Outside the San Diego mosque where his father was gunned down by heavily armed teenagers who had been radicalized online, Ramzy sits and stares blankly.
Google wants its search bar to act on your behalf in AI revamp
Google on Tuesday showed off new plans to turn its famous search bar into an AI assistant that can book restaurants, track news and contact businesses -- just by asking a question.
Pakistan court sentences man to death for killing teen influencer
A Pakistani court sentenced a man to death on Tuesday for murdering a teenage influencer last year after she had repeatedly rejected his advances.
Mango founder's son arrested in Spain over father's death
Spanish police said Tuesday they have arrested the eldest son of Mango clothing empire founder Isak Andic over his father's death during a hiking trip in December 2024.
US police investigating deadly mosque shooting as hate crime
Police were investigating a shooting in the US state of California as a hate crime on Tuesday after a pair of teenage gunmen killed three people at a mosque complex.
Government encourages women to report rape in French star's assault probes
The French government spokeswoman on Tuesday encouraged women to speak out about sexual violence, "even decades later," as she addressed mounting allegations of rape and assault targeting popular singer and actor Patrick Bruel.
Three killed in San Diego mosque shooting, both suspects dead
A shooting Monday at a mosque complex in southern California killed three people, with two suspected teenage gunmen later found dead in a car from apparent self-inflicted gunshot wounds, police said.
Campaigners warn Italy's gutted rape bill could help assailants
An attempt in Italy to introduce a consent-based rape law is floundering and experts warn rapists could stand to gain after the far right torpedoed an "only yes means yes" definition.
Libyan ex-prison boss faces ICC war crimes hearing
A former boss of a notorious Libyan prison faces three days of hearings at the International Criminal Court from Tuesday, accused of war crimes including murder, rape and torture.
Star of Rome's 'sexy priest' calendar admits: 'I was never a priest'
His face smiles out from every kiosk in Rome on the cover of the ubiquitous "sexy priest" calendar sold to tourists but Giovanni Galizia was never a man of the cloth.
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
VANCOUVER, BC / ACCESS Newswire / May 19, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated April 28, 2026, continued progress in the intermediate1 scale-up and process development activities for the A83 and B4 precursor components supporting the Company's lead oncology program, ONC010, a novel nanoparticle-formulated PNKP inhibitor currently advancing through IND-enabling development.
Bouka Family Sets Out Again to Conquer Everest
Inspiring resilience
AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform
Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of Excellence as its first European operation.
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
First MVID patient enters the active treatment only extension phase after completion of randomized double-blind crossover period to evaluate longer-term safety and efficacy with liquid oral crofelemer as adjunctive treatment for MVID, an ultrarare pediatric disease with a lethal natural history and no approved therapies, requiring lifelong parenteral support (PS)
BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development
VANCOUVER, BC / ACCESS Newswire / May 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its Semaglutide oral dissolvable film ("ODF") program has entered the active pharmaceutical development phase in collaboration with German drug development partner Gen-Plus GmbH.
Harry Styles fans to splash over £1 bn on London concerts: Barclays
Harry Styles' dozen concerts in London this summer will see fans spend more than £1.0 billion ($1.3 billion) combined on tickets and costs including accommodation and travel, Barclays forecast Tuesday.
Three killed in San Diego mosque shooting, two attackers dead
A shooting at a mosque complex in California killed three people Monday, with two suspected teenage gunmen later found dead in a car from self-inflicted gunshot wounds, police said.
After mayor's murder, Mexico battles to bring peace
The brazen murder of a small-city mayor shocked Mexico and forced President Claudia Sheinbaum to step up an offensive against all-powerful drug cartels.
Musk loses blockbuster OpenAI suit as jury says too late
A federal jury ruled Monday that Elon Musk waited too long to sue OpenAI and its co-founders, delivering a decisive victory to OpenAI CEO Sam Altman and ending one of Silicon Valley's most closely watched courtroom battles.
First attack on Arab nuclear site sends warning to Gulf, US
The first attack targeting an Arab nuclear site has sent a symbolic warning to the United Arab Emirates and its allies, even as Iran and the US remain in negotiations to end the Middle East war, analysts say.
Hantavirus-hit cruise ship docks in Rotterdam at voyage end
A cruise ship that sparked global alarm after a deadly outbreak of hantavirus docked in Rotterdam harbour Monday, with the skeleton crew facing weeks of quarantine.
Train driver charged after deadly Bangkok bus collision
The driver of a train that collided with a bus in Thailand's capital, killing eight people, has tested positive for drugs and was charged with reckless driving, police said Monday.
Encroaching world threatens India's last 'uncontacted' tribe
One of the last outsiders to make authorised visits to India's only "uncontacted" tribe says it may be time to reconnect with the isolated people -- in order to shield them from an encroaching world.
Four takeaways from Musk vs OpenAI trial
After three weeks of intense hearings,Silicon Valley's first major AI trial -- over the lawsuit filed by Elon Musk against the co-founders of OpenAI -- is nearing an end. It is expected to go to the jury on Monday.
'Staggering' Iran toll drives up global executions: Amnesty
Iran put to death over 2,150 people last year, a "staggering" increase that pushed recorded worldwide executions to their highest level since 1981, Amnesty International said Monday.
NanoViricides Announces Closing of ~$2 Million Registered Direct Offering
SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical stage, leading ghttp://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=333-271706l pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses and their variants cannot escape, today announced the closing of its previously announced registered direct offering (the "Offering") of 1,333,334 million shares of common stock (or pre-funded warrants in lieu thereof), together with accompanying warrants to purchase 1,333,334 common shares (the "Offering"). The Offering was made to a single, fundamental institutional investor and priced at-the-market price of US$1.50 for each common share and accompanying whole warrant to purchase one common share. Each whole warrant has an exercise price of US$1.75 per share and will be exercisable six months from issuance and will expire in three years. The Company received aggregate gross proceeds of $2,000,001 from the Offering, before deducting placement agent fees and other related expenses.